Annual EBITDA
-$6.89 M
+$3.97 M+36.57%
31 December 2023
Summary:
Adial Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$6.89 million, with the most recent change of +$3.97 million (+36.57%) on 31 December 2023. During the last 3 years, it has risen by +$4.04 million (+36.97%). ADIL annual EBITDA is now -1579.85% below its all-time high of -$410.00 thousand, reached on 31 December 2016.ADIL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.21 M
+$75.80 K+3.31%
30 September 2024
Summary:
Adial Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.21 million, with the most recent change of +$75.80 thousand (+3.31%) on 30 September 2024. Over the past year, it has dropped by -$853.50 thousand (-62.86%). ADIL quarterly EBITDA is now -2430.09% below its all-time high of -$87.40 thousand, reached on 31 December 2016.ADIL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$8.13 M
-$853.50 K-11.73%
30 September 2024
Summary:
Adial Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$8.13 million, with the most recent change of -$853.50 thousand (-11.73%) on 30 September 2024. Over the past year, it has dropped by -$425.90 thousand (-5.53%). ADIL TTM EBITDA is now -8392.16% below its all-time high of -$95.70 thousand, reached on 30 June 2016.ADIL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADIL EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.6% | -62.9% | -5.5% |
| 3 y3 years | +37.0% | +45.4% | +51.5% |
| 5 y5 years | +34.2% | -26.7% | -12.3% |
ADIL EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.1% | -62.9% | +49.9% | -25.7% | +54.0% |
| 5 y | 5 years | at high | +61.1% | -62.9% | +54.2% | -25.7% | +54.0% |
| alltime | all time | -1579.8% | +61.1% | -2430.1% | +69.8% | -8392.2% | +54.0% |
Adial Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.21 M(-3.3%) | -$8.13 M(+11.7%) |
| June 2024 | - | -$2.29 M(+24.0%) | -$7.27 M(+12.5%) |
| Mar 2024 | - | -$1.84 M(+3.4%) | -$6.46 M(-6.2%) |
| Dec 2023 | -$6.89 M(-36.6%) | -$1.78 M(+31.4%) | -$6.89 M(-10.6%) |
| Sept 2023 | - | -$1.36 M(-8.1%) | -$7.70 M(-13.4%) |
| June 2023 | - | -$1.48 M(-34.9%) | -$8.90 M(-16.6%) |
| Mar 2023 | - | -$2.27 M(-12.7%) | -$10.66 M(-6.8%) |
| Dec 2022 | -$10.86 M(-38.6%) | -$2.60 M(+1.7%) | -$11.44 M(-13.7%) |
| Sept 2022 | - | -$2.55 M(-21.2%) | -$13.26 M(-10.1%) |
| June 2022 | - | -$3.24 M(+6.6%) | -$14.76 M(-7.2%) |
| Mar 2022 | - | -$3.04 M(-31.1%) | -$15.90 M(-10.1%) |
| Dec 2021 | -$17.69 M(+61.8%) | -$4.42 M(+9.0%) | -$17.69 M(+5.7%) |
| Sept 2021 | - | -$4.05 M(-7.7%) | -$16.74 M(+4.4%) |
| June 2021 | - | -$4.39 M(-9.1%) | -$16.03 M(+19.1%) |
| Mar 2021 | - | -$4.83 M(+39.1%) | -$13.46 M(+23.1%) |
| Dec 2020 | -$10.93 M | -$3.47 M(+4.0%) | -$10.93 M(+14.5%) |
| Sept 2020 | - | -$3.34 M(+83.5%) | -$9.55 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$1.82 M(-20.9%) | -$7.96 M(-4.1%) |
| Mar 2020 | - | -$2.30 M(+10.0%) | -$8.30 M(+0.6%) |
| Dec 2019 | -$8.24 M(-21.2%) | -$2.09 M(+19.8%) | -$8.24 M(+13.9%) |
| Sept 2019 | - | -$1.75 M(-19.1%) | -$7.24 M(-43.5%) |
| June 2019 | - | -$2.16 M(-4.0%) | -$12.80 M(+3.4%) |
| Mar 2019 | - | -$2.25 M(+107.7%) | -$12.39 M(+18.4%) |
| Dec 2018 | -$10.46 M(+952.3%) | -$1.08 M(-85.2%) | -$10.46 M(+7.8%) |
| Sept 2018 | - | -$7.31 M(+320.0%) | -$9.70 M(+265.8%) |
| June 2018 | - | -$1.74 M(+432.3%) | -$2.65 M(+130.2%) |
| Mar 2018 | - | -$327.10 K(+1.7%) | -$1.15 M(+15.9%) |
| Dec 2017 | -$994.40 K(+142.5%) | -$321.70 K(+22.6%) | -$994.40 K(+30.8%) |
| Sept 2017 | - | -$262.30 K(+8.7%) | -$760.10 K(+26.8%) |
| June 2017 | - | -$241.30 K(+42.7%) | -$599.40 K(+32.1%) |
| Mar 2017 | - | -$169.10 K(+93.5%) | -$453.80 K(+59.4%) |
| Dec 2016 | -$410.00 K(-49.8%) | -$87.40 K(-14.0%) | -$284.70 K(+44.3%) |
| Sept 2016 | - | -$101.60 K(+6.2%) | -$197.30 K(+106.2%) |
| June 2016 | - | -$95.70 K | -$95.70 K |
| Dec 2015 | -$817.40 K | - | - |
FAQ
- What is Adial Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual EBITDA year-on-year change?
- What is Adial Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Adial Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM EBITDA year-on-year change?
What is Adial Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ADIL is -$6.89 M
What is the all time high annual EBITDA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$410.00 K
What is Adial Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ADIL annual earnings before interest, taxes, depreciation & amortization has changed by +$3.97 M (+36.57%)
What is Adial Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ADIL is -$2.21 M
What is the all time high quarterly EBITDA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$87.40 K
What is Adial Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ADIL quarterly earnings before interest, taxes, depreciation & amortization has changed by -$853.50 K (-62.86%)
What is Adial Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ADIL is -$8.13 M
What is the all time high TTM EBITDA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$95.70 K
What is Adial Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ADIL TTM earnings before interest, taxes, depreciation & amortization has changed by -$425.90 K (-5.53%)